$IBRX short primer
$IBRX is a commercial stage biotech founder by the legendary asian doctor @DrPatrick with the mission to find cure for cancer.
The company is on track to achieving its mission with its flagship drug ANKTIVA, which has been approved in the US (limited use) and in the Saudi (broader usage).
If successful, the company is well-poised to take a leading position in the global oncology market.
Recent signals suggest strong upward momentum, after the 750% revenue increased and the Saudi's approval for its Lung cancer treatment.
Discovered my Gas ID via ETHGas - turning my gas spend into rewards 🫘
As a Teen Jack, I've spent 0.5308 ETH on gas but earned 180 Beans back.
Get your Gas ID and Beans here: https://t.co/xyqiJ4qXfr